https://api.elsevier.com/content/article/pii/S0264410X14006975doi:10.1016/j.vaccine.2014.05.0301-s2.0-S0264410X1400697510.1016/j.vaccine.2014.05.030S0264-410X(14)00697-5Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers VaccineJournal0264410X2014-09-033 September 20140falsefalse